Profound Medical Corp Stock Today
| PROF Stock | USD 7.35 0.08 1.08% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Profound Medical is trading at 7.35 as of the 17th of January 2025. This is a 1.08% down since the beginning of the trading day. The stock's lowest day price was 7.22. Profound Medical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 18th of November 2024 and ending today, the 17th of January 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 9th of June 2016 | Category Healthcare | Classification Health Care |
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. The company has 30.03 M outstanding shares of which 369.85 K shares are at this time shorted by private and institutional investors with about 4.28 trading days to cover. More on Profound Medical Corp
Moving against Profound Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Profound Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsProfound Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Profound Medical's financial leverage. It provides some insight into what part of Profound Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Profound Medical Corp (PROF) is traded on NASDAQ Exchange in USA. It is located in 2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5 and employs 131 people. Profound Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 223.11 M. Profound Medical Corp conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 30.03 M outstanding shares of which 369.85 K shares are at this time shorted by private and institutional investors with about 4.28 trading days to cover.
Profound Medical Corp currently holds about 46.21 M in cash with (22.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.21.
Check Profound Medical Probability Of Bankruptcy
Ownership AllocationProfound Medical owns a total of 30.03 Million outstanding shares. 30% of Profound Medical Corp outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Profound Ownership Details
Profound Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Bleichroeder Lp | 2024-09-30 | 133.3 K | |
| Td Asset Management Inc | 2024-09-30 | 124.3 K | |
| Thompson Davis & Co Inc | 2024-09-30 | 101.9 K | |
| Connor Clark & Lunn Inv Mgmt Ltd | 2024-09-30 | 76.9 K | |
| Renaissance Technologies Corp | 2024-09-30 | 58.9 K | |
| Millennium Management Llc | 2024-09-30 | 53.6 K | |
| K2 Principal Fund Lp | 2024-09-30 | 50 K | |
| Chilton Investment Company, Inc. | 2024-09-30 | 45 K | |
| Raymond James & Associates | 2024-09-30 | 43 K | |
| Fidelity International Ltd | 2024-09-30 | 1.5 M | |
| Gagnon Securities Llc | 2024-09-30 | 1.5 M |
Profound Medical Historical Income Statement
Profound Stock Against Markets
Profound Medical Corporate Management
| Arun MBA | Chairman CEO | Profile | |
| Hartmut Warnken | Senior Alliances | Profile | |
| Jacques Cornet | Senior Sonalleve | Profile | |
| Stephen Kilmer | Investor Relations | Profile | |
| Mathieu Burtnyk | Senior TULSAPRO | Profile | |
| Thomas MBA | Chief Officer | Profile | |
| Abbey Goodman | Chief Global | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.35) | Revenue Per Share | Quarterly Revenue Growth 0.639 | Return On Assets | Return On Equity |
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.